Humans need not apply.
With predictable consequences.
FB’s psychological experimentation on hundreds of thousands of unwitting users is illicit human experimentation and a gross human-rights violation.
When you buy health insurance, you only think you know what you’re buying. You know parameters such as the deductible, coinsurance, and other nonspecific things. But the devil doesn’t lurk in nonspecific things.
By Michael Gorback, M.D.: Confused and outraged by the prices, often unknown upfront, that you and your insurance company pay for medical services? You’re not the only one. Enter the bizarre world of “Place of Service” pricing.
“Professional bullying from administrators to run both a pill mill and a needle jockey business was tremendous. I resisted the entire time. But god, it wore me out.”
At first, it was just multinational drugmaker GlaxoSmithKline that allegedly paid bribes in China, including “sexual bribes,” to “government officials, medical associations, hospitals and doctors,” by using travel agencies as conduit. For a total of $489 million. Now more big drugmakers are on the hot seat for the same crimes in China – and in the US.
Facebook isn’t over the hill, exactly. Last October, it announced that 1 billion people a month used it, in a world of 7 billion. Leaping from one milestone to the next. But in key markets, such as the US where it derives most of its revenues, it is plateauing, and a shudder-inducing D-word has snuck into polite conversation: declining. Now we have a new reason.
Congress excels at enriching corporate welfare programs—in this case, Medicare. Ironically, it happened while Congress is struggling to rein in Medicare’s gargantuan deficits with belt-tightening measures that would hit people who paid into the system throughout their working years. This time, the prime beneficiary was Big Pharma, particularly one company….
A sadly familiar theme in the US—the growing ranks of the working poor—was fleshed out today. But the report did something else: it added graphic details to the conundrum of US healthcare spending: while it ballooned to $2.7 trillion, 17.9% of GDP, or $8,680 per capita, households have lowered their share. So have businesses. What gives?